Earnings · China A-shares
Beijing Balance Medical Technology Co. Ltd. Class A (688198) earnings
Beijing Balance Medical Technology Co. Ltd. Class A published its Q3 report on 2026-10-28: net profit -17.41% year on year, -11.94% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.04% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -17.41%
- Excl. one-offs YoY
- -11.94%
- Net profit QoQ
- +1201.24%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.01% | — |
| 3 days | -0.04% | — |
| 7 days | -0.52% | — |
| 14 days | -7.61% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 0 of 6 reports (average -3.65%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥76.55M | -17.41% | -11.94% | +8.59% | 0.56 | 5.66% | -0.04% | — | — |
| 2026 interim report | 2026-08-27 | ¥43.89M | -38.54% | -38.85% | +2.35% | 0.32 | 3.25% | -6.62% | -11.09% | -2.15% |
| 2026 Q1 report | 2026-04-22 | ¥41.38M | +27.29% | +73.64% | +43.36% | 0.30 | 3.07% | -0.42% | -21.10% | -22.69% |
| 2025 annual report | 2026-04-22 | ¥193.57M | +32.28% | +27.96% | +23.57% | 1.41 | 15.03% | -0.42% | -21.10% | -22.69% |
| 2025 Q3 report | 2025-10-31 | ¥92.70M | +57.93% | +44.84% | +30.58% | 0.67 | 7.39% | -2.86% | +2.20% | +6.88% |
| 2025 interim report | 2025-08-28 | ¥71.40M | +102.90% | +88.55% | +30.07% | 0.52 | 5.61% | -5.62% | -13.42% | -18.92% |
| 2025 Q1 report | 2025-04-25 | ¥32.50M | +290.69% | +261.55% | +31.30% | 0.24 | 2.57% | -6.31% | -10.24% | -13.48% |
| 2024 annual report | 2025-04-25 | ¥146.33M | +27.02% | +37.54% | +35.41% | 1.07 | 12.08% | -6.31% | -10.24% | -13.48% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.